DURVA TAILA IN URETHRAL STRICTURE

EFFICACY OF DURVA TAILA UTTARBASTI IN THE MANAGEMENT OF STRICURE URETHRA AN OPEN LABELLED CLINICAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056112

Enrollment

Registered

2023-08-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N359- Urethral stricture, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Stricture Urethra will be included Patients of either gender of age 25 TO 75years with history of stricture urethra of mild to moderate symptoms will be selected for the study

Exclusion criteria

Exclusion criteria: Age group below 25 years and above 75 years Patients of impacted calculus in the urethra and bladder Neck Benign Prostatic Hyperplasia Uncontrolled Diabetes Mellitus Nephritic Syndrome and Neoplasm of lower urinary tract Congenital and severely symptomatic Stricture Urethra HIV and HbsAg positive Carcinoma patients

Design outcomes

Primary

Measure	Time frame
WILL REDUCE THE SYMPTOMS OF URETHRAL STRICTURE EG DRIBBLING MICTURITION URINE STREAM WITHIN 7 DAYS WITH UTTARBASTITimepoint: 7 DAYS	—

Secondary

Measure	Time frame
IMPROVE THE QUALITY OF LIFE AND REDUCE SYMPTOMS OF URETHRAL STRICTURETimepoint: 7 DAYS	—

Countries

India

Contacts

Public ContactDR HEMANT TOSHIKHANE

PARUL INSTITUTE OF AYURVED

Drhemantt@gmail.com8469496525

Outcome results